The PedsQL™ -: Reliability and validity of the short-form generic core scales and asthma module

The PedsQL™ -: Reliability and validity of the short-form generic core scales and asthma module
复制标题

DOI:
10.1097/00005650-200503000-00008
复制
发表时间:
2005-03-01
期刊:
影响因子:
3
通讯作者:
Varni, JW
Varni, JW
中科院分区:
医学3区
文献类型:
--
作者:
Chan, KS;Mangione-Smith, R;Varni, JW

文献摘要

被引文献

相似文献

目的:我们试图评估PedsQL(TM)4.0 SF 15(23项PedsQL(TM)4.0通用核心量表的缩短版本,这是一种儿科健康相关生活质量(HRQoL)工具)和PedsQL(TM)3.0 SF 22哮喘模块(PedsQL(TM)3.0哮喘模块的简化形式)的可靠性和有效性。方法:通过电话对125名青少年(12-18岁)和338名哮喘儿童(2-11岁)的父母进行了PedsQL(TM)4.0 SF 15和PedsQL(TM)3.0 SF 22哮喘模块。健康儿童(n = 451)和慢性病儿童(n = 422)按年龄、应答状态和种族与哮喘样本相匹配,为选定的有效性测试提供数据。PedsQL(TM)4.0 SF 15的总评分和PedsQL(TM)3.0 SF 22哮喘模块的哮喘症状量表和治疗问题量表对于组间比较而言足够可靠(所有年龄组的α大于或等于0.70)。PedsQL(TM)4.0 SF 15和PedsQL(TM)3.0 SF 22哮喘模块能够区分不同临床状态的儿童,并与哮喘样本中的生产力和家庭功能指标相关。PedsQL(TM)4.0 SF 15的心理测量特性与原始仪器的心理测量特性大体相当。PedsQL(TM)4.0 SF 15的总分和PedsQL(TM)3.0 SF 22哮喘模块的哮喘症状量表显示了最佳的可靠性和有效性,应适用于一般哮喘和哮喘的组水平比较。儿童哮喘临床研究中的特定HRQoL。
Objective: We sought to assess the reliability and validity of the PedsQL(TM) 4.0 SF15, a shortened version of the 23-item PedsQL(TM) 4.0 Generic Core Scales, which is a pediatric health-related quality of life (HRQoL) instrument, and the PedsQL(TM) 3.0 SF22 Asthma Module, a short-form of the PedsQL(TM) 3.0 Asthma Module.Methods: The PedsQL(TM) 4.0 SF15 and the PedsQL(TM) 3.0 SF22 Asthma Module were administered by telephone to 125 adolescents (aged 12-18) and 338 parents of children with asthma (aged 2-11). Healthy (n = 451) and chronically ill (n = 422) children, matched by age, respondent status, and ethnicity to the asthma sample, provided data for selected validity tests.Results: The Total Score from the PedsQL(TM) 4.0 SF15 and the Asthma Symptoms scale and Treatment Problems scale from the PedsQL(TM) 3.0 SF22 Asthma Module were sufficiently reliable for group comparisons (alpha greater than or equal to 0.70 across all age groups) in the asthma sample. The PedsQL(TM) 4.0 SF15 and the PedsQL(TM) 3.0 SF22 Asthma Module were able to distinguish between children of different clinical status and correlated as expected with measures of productivity and family functioning in the asthma sample. The psychometric properties of the PedsQL(TM) 4.0 SF15 were generally comparable to those of the original instrument.Conclusion: The Total Score of the PedsQL(TM) 4.0 SF15 and the Asthma Symptoms scale of the PedsQL(TM) 3.0 SF22 Asthma Module demonstrated the best reliability and validity and should be suitable for group-level comparisons of generic and asthma-specific HRQoL in clinical research studies of children with asthma.